<DOC>
	<DOCNO>NCT03026556</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness newly initiate dabigatran among patient diagnose non valvular atrial fibrillation ( NVAF ) comparison newly initiate rivaroxaban user newly initiate apixaban user</brief_summary>
	<brief_title>The Comparative Safety Effectiveness Dabigatran , Versus Rivaroxaban , Apixaban Utilized Department Defense Non-Valvular Atrial Fibrillation Patient Population : A Retrospective Database Analysis</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Age 18+ index date Patients must prescribe either dabigatran , rivaroxaban , apixaban identify pharmacy claim study period . The first dispensing date either study drug define index date ; Patients must treatment na√Øve OAC use prior first NOAC prescription , study period . Patients must least 12 month continuous eligibility prior index date ; Patients must least one diagnosis code atrial fibrillation , define ICD 9CM diagnosis 427.31 ICD10CM diagnosis I48.0 , I48.1 , I48.2 , I48.91 index date preindex period . Less 12 month continuous eligibility preindex period Any claim OAC drug ( oral use ) preindex period Diagnosis hyperthyroidism preindex period Having least one claim alternative indication ; orthopedic procedure , VTE ( include DVT &amp; PE ) index NOAC prescription time , , alternative indication anticoagulant occur within 3 month prior index date preperiod Having least one claim follow diagnosis procedure code order exclude patient `` transient '' cause Afib ( 3 month prior index date preperiod ) : Cardiac surgery Pericarditis Myocarditis Having least one medical claim follow diagnosis procedure code order exclude patient `` valvular '' Afib ( preperiod ) : Mitral stenosis Mitral stenosis insufficiency Mitral valve stenosis aortic valve stenosis Mitral valve stenosis aortic valve insufficiency Diseases endocardial structure Other unspecified rheumatic heart diseases Open heart valvuloplasty without replacement Open replacement unspecified heart valve Open replacement aortic valve Open replacement mitral valve Open replacement pulmonary valve Open replacement tricuspid valve Heart valve replace transplant Heart valve replace mechanical device/prosthesis Atrioventricular valve repair Aortic valve valvuloplasty Unlisted procedure , cardiac surgery Implantation catheterdelivered prosthetic aortic heart valve ; open thoracic approach Transthoracic cardiac exposure ( e.g. , sternotomy , thoracotomy , subxiphoid ) catheterdelivered aortic valve replacement ; without cardiopulmonary bypass Transthoracic cardiac exposure ( e.g. , sternotomy , thoracotomy , subxiphoid ) catheterdelivered aortic valve replacement ; cardiopulmonary bypass Replacement , aortic valve , cardiopulmonary bypass ; prosthetic valve homograft stentless valve Valvuloplasty , mitral valve , cardiopulmonary bypass Valvuloplasty , mitral valve , cardiopulmonary bypass ; prosthetic ring Valvuloplasty , mitral valve , cardiopulmonary bypass ; radical reconstruction , without ring Replacement , mitral valve , cardiopulmonary bypass Implantation catheterdelivered prosthetic pulmonary valve , endovascular approach Replacement , pulmonary valve Valvectomy , tricuspid valve , cardiopulmonary bypass Valvuloplasty , tricuspid valve ; without ring insertion Valvuloplasty , tricuspid valve ; ring insertion Replacement , tricuspid valve , cardiopulmonary bypass</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>